Fecal microbiota dynamics during disease activity and remission in newly diagnosed and established ulcerative colitis

Abstract Patients with ulcerative colitis (UC) have an altered gut microbiota composition, but the microbial relationship to disease activity needs to be further elucidated. Therefore, temporal dynamics of the fecal microbial community during remission and flare was determined. Fecal samples were co...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Lena Öhman, Anders Lasson, Anna Strömbeck, Stefan Isaksson, Marcus Hesselmar, Magnus Simrén, Hans Strid, Maria K. Magnusson
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/888e6863e5fa45338bf1f85f53a2768b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:888e6863e5fa45338bf1f85f53a2768b
record_format dspace
spelling oai:doaj.org-article:888e6863e5fa45338bf1f85f53a2768b2021-12-02T13:39:34ZFecal microbiota dynamics during disease activity and remission in newly diagnosed and established ulcerative colitis10.1038/s41598-021-87973-72045-2322https://doaj.org/article/888e6863e5fa45338bf1f85f53a2768b2021-04-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-87973-7https://doaj.org/toc/2045-2322Abstract Patients with ulcerative colitis (UC) have an altered gut microbiota composition, but the microbial relationship to disease activity needs to be further elucidated. Therefore, temporal dynamics of the fecal microbial community during remission and flare was determined. Fecal samples were collected at 2–6 time-points from UC patients during established disease (cohort EST) and at diagnosis (cohort NEW). Sampling range for cohort EST was 3–10 months and for cohort NEW 36 months. Relapses were monitored for an additional three years for cohort EST. Microbial composition was assessed by Genetic Analysis GA-map Dysbiosis Test, targeting ≥ 300 bacteria. Eighteen patients in cohort EST (8 with maintained remission and 10 experiencing a flare), provided 71 fecal samples. In cohort NEW, 13 patients provided 49 fecal samples. The microbial composition showed no clustering related to disease activity in any cohort. Microbial dissimilarity was higher between than within patients for both cohorts, irrespective of presence of a flare. Microbial stability within patients was constant over time with no major shift in overall composition nor modification in the abundance of any specific species. Microbial composition was not affected by intensified medical treatment or linked to future disease course. Thus in UC, the gut microbiota is highly stable irrespective of disease stage, disease activity or treatment escalation. This suggests that prolonged dietary interventions or repeated fecal transplantations are needed to be able to induce permanent alterations of the gut microbiota.Lena ÖhmanAnders LassonAnna StrömbeckStefan IsakssonMarcus HesselmarMagnus SimrénHans StridMaria K. MagnussonNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Lena Öhman
Anders Lasson
Anna Strömbeck
Stefan Isaksson
Marcus Hesselmar
Magnus Simrén
Hans Strid
Maria K. Magnusson
Fecal microbiota dynamics during disease activity and remission in newly diagnosed and established ulcerative colitis
description Abstract Patients with ulcerative colitis (UC) have an altered gut microbiota composition, but the microbial relationship to disease activity needs to be further elucidated. Therefore, temporal dynamics of the fecal microbial community during remission and flare was determined. Fecal samples were collected at 2–6 time-points from UC patients during established disease (cohort EST) and at diagnosis (cohort NEW). Sampling range for cohort EST was 3–10 months and for cohort NEW 36 months. Relapses were monitored for an additional three years for cohort EST. Microbial composition was assessed by Genetic Analysis GA-map Dysbiosis Test, targeting ≥ 300 bacteria. Eighteen patients in cohort EST (8 with maintained remission and 10 experiencing a flare), provided 71 fecal samples. In cohort NEW, 13 patients provided 49 fecal samples. The microbial composition showed no clustering related to disease activity in any cohort. Microbial dissimilarity was higher between than within patients for both cohorts, irrespective of presence of a flare. Microbial stability within patients was constant over time with no major shift in overall composition nor modification in the abundance of any specific species. Microbial composition was not affected by intensified medical treatment or linked to future disease course. Thus in UC, the gut microbiota is highly stable irrespective of disease stage, disease activity or treatment escalation. This suggests that prolonged dietary interventions or repeated fecal transplantations are needed to be able to induce permanent alterations of the gut microbiota.
format article
author Lena Öhman
Anders Lasson
Anna Strömbeck
Stefan Isaksson
Marcus Hesselmar
Magnus Simrén
Hans Strid
Maria K. Magnusson
author_facet Lena Öhman
Anders Lasson
Anna Strömbeck
Stefan Isaksson
Marcus Hesselmar
Magnus Simrén
Hans Strid
Maria K. Magnusson
author_sort Lena Öhman
title Fecal microbiota dynamics during disease activity and remission in newly diagnosed and established ulcerative colitis
title_short Fecal microbiota dynamics during disease activity and remission in newly diagnosed and established ulcerative colitis
title_full Fecal microbiota dynamics during disease activity and remission in newly diagnosed and established ulcerative colitis
title_fullStr Fecal microbiota dynamics during disease activity and remission in newly diagnosed and established ulcerative colitis
title_full_unstemmed Fecal microbiota dynamics during disease activity and remission in newly diagnosed and established ulcerative colitis
title_sort fecal microbiota dynamics during disease activity and remission in newly diagnosed and established ulcerative colitis
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/888e6863e5fa45338bf1f85f53a2768b
work_keys_str_mv AT lenaohman fecalmicrobiotadynamicsduringdiseaseactivityandremissioninnewlydiagnosedandestablishedulcerativecolitis
AT anderslasson fecalmicrobiotadynamicsduringdiseaseactivityandremissioninnewlydiagnosedandestablishedulcerativecolitis
AT annastrombeck fecalmicrobiotadynamicsduringdiseaseactivityandremissioninnewlydiagnosedandestablishedulcerativecolitis
AT stefanisaksson fecalmicrobiotadynamicsduringdiseaseactivityandremissioninnewlydiagnosedandestablishedulcerativecolitis
AT marcushesselmar fecalmicrobiotadynamicsduringdiseaseactivityandremissioninnewlydiagnosedandestablishedulcerativecolitis
AT magnussimren fecalmicrobiotadynamicsduringdiseaseactivityandremissioninnewlydiagnosedandestablishedulcerativecolitis
AT hansstrid fecalmicrobiotadynamicsduringdiseaseactivityandremissioninnewlydiagnosedandestablishedulcerativecolitis
AT mariakmagnusson fecalmicrobiotadynamicsduringdiseaseactivityandremissioninnewlydiagnosedandestablishedulcerativecolitis
_version_ 1718392629352202240